Cargando…
Survival of tumor cells after proton irradiation with ultra-high dose rates
BACKGROUND: Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-driven particle beams are pulsed and ultra high dose rates of >10(9 )Gy s(-1)may be achieved. Here we compare the radiobiological effects of pulsed and continuous proton beams. METHODS:...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215966/ https://www.ncbi.nlm.nih.gov/pubmed/22008289 http://dx.doi.org/10.1186/1748-717X-6-139 |
_version_ | 1782216451605659648 |
---|---|
author | Auer, Susanne Hable, Volker Greubel, Christoph Drexler, Guido A Schmid, Thomas E Belka, Claus Dollinger, Günther Friedl, Anna A |
author_facet | Auer, Susanne Hable, Volker Greubel, Christoph Drexler, Guido A Schmid, Thomas E Belka, Claus Dollinger, Günther Friedl, Anna A |
author_sort | Auer, Susanne |
collection | PubMed |
description | BACKGROUND: Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-driven particle beams are pulsed and ultra high dose rates of >10(9 )Gy s(-1)may be achieved. Here we compare the radiobiological effects of pulsed and continuous proton beams. METHODS: The ion microbeam SNAKE at the Munich tandem accelerator was used to directly compare a pulsed and a continuous 20 MeV proton beam, which delivered a dose of 3 Gy to a HeLa cell monolayer within < 1 ns or 100 ms, respectively. Investigated endpoints were G2 phase cell cycle arrest, apoptosis, and colony formation. RESULTS: At 10 h after pulsed irradiation, the fraction of G2 cells was significantly lower than after irradiation with the continuous beam, while all other endpoints including colony formation were not significantly different. We determined the relative biological effectiveness (RBE) for pulsed and continuous proton beams relative to x-irradiation as 0.91 ± 0.26 and 0.86 ± 0.33 (mean and SD), respectively. CONCLUSIONS: At the dose rates investigated here, which are expected to correspond to those in radiation therapy using laser-driven particles, the RBE of the pulsed and the (conventional) continuous irradiation mode do not differ significantly. |
format | Online Article Text |
id | pubmed-3215966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32159662011-11-16 Survival of tumor cells after proton irradiation with ultra-high dose rates Auer, Susanne Hable, Volker Greubel, Christoph Drexler, Guido A Schmid, Thomas E Belka, Claus Dollinger, Günther Friedl, Anna A Radiat Oncol Research BACKGROUND: Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-driven particle beams are pulsed and ultra high dose rates of >10(9 )Gy s(-1)may be achieved. Here we compare the radiobiological effects of pulsed and continuous proton beams. METHODS: The ion microbeam SNAKE at the Munich tandem accelerator was used to directly compare a pulsed and a continuous 20 MeV proton beam, which delivered a dose of 3 Gy to a HeLa cell monolayer within < 1 ns or 100 ms, respectively. Investigated endpoints were G2 phase cell cycle arrest, apoptosis, and colony formation. RESULTS: At 10 h after pulsed irradiation, the fraction of G2 cells was significantly lower than after irradiation with the continuous beam, while all other endpoints including colony formation were not significantly different. We determined the relative biological effectiveness (RBE) for pulsed and continuous proton beams relative to x-irradiation as 0.91 ± 0.26 and 0.86 ± 0.33 (mean and SD), respectively. CONCLUSIONS: At the dose rates investigated here, which are expected to correspond to those in radiation therapy using laser-driven particles, the RBE of the pulsed and the (conventional) continuous irradiation mode do not differ significantly. BioMed Central 2011-10-18 /pmc/articles/PMC3215966/ /pubmed/22008289 http://dx.doi.org/10.1186/1748-717X-6-139 Text en Copyright ©2011 Auer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Auer, Susanne Hable, Volker Greubel, Christoph Drexler, Guido A Schmid, Thomas E Belka, Claus Dollinger, Günther Friedl, Anna A Survival of tumor cells after proton irradiation with ultra-high dose rates |
title | Survival of tumor cells after proton irradiation with ultra-high dose rates |
title_full | Survival of tumor cells after proton irradiation with ultra-high dose rates |
title_fullStr | Survival of tumor cells after proton irradiation with ultra-high dose rates |
title_full_unstemmed | Survival of tumor cells after proton irradiation with ultra-high dose rates |
title_short | Survival of tumor cells after proton irradiation with ultra-high dose rates |
title_sort | survival of tumor cells after proton irradiation with ultra-high dose rates |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215966/ https://www.ncbi.nlm.nih.gov/pubmed/22008289 http://dx.doi.org/10.1186/1748-717X-6-139 |
work_keys_str_mv | AT auersusanne survivaloftumorcellsafterprotonirradiationwithultrahighdoserates AT hablevolker survivaloftumorcellsafterprotonirradiationwithultrahighdoserates AT greubelchristoph survivaloftumorcellsafterprotonirradiationwithultrahighdoserates AT drexlerguidoa survivaloftumorcellsafterprotonirradiationwithultrahighdoserates AT schmidthomase survivaloftumorcellsafterprotonirradiationwithultrahighdoserates AT belkaclaus survivaloftumorcellsafterprotonirradiationwithultrahighdoserates AT dollingergunther survivaloftumorcellsafterprotonirradiationwithultrahighdoserates AT friedlannaa survivaloftumorcellsafterprotonirradiationwithultrahighdoserates |